Florent Grange

ORCID：0000-0003-3387-0283

发表论文 312 篇 · 总被引 13363 次 · h-index 51

代表论文

• Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study (2025 · The Lancet Oncology · 被引 12)
• Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients (2024 · Histopathology · 被引 9)
• Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study. (2024 · Journal of Clinical Oncology · 被引 8)
• Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study) (2024 · British Journal of Dermatology · 被引 8)
• Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL) (2025 · British Journal of Dermatology · 被引 7)
• Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score–Matched Controlled Prospective Study (2025 · Journal of Clinical Oncology · 被引 7)